Literature DB >> 1655100

Choice of treatments for small hepatocellular carcinoma: hepatectomy, embolization or ethanol injection.

S Yamasaki1, H Hasegawa, M Makuuchi, T Takayama, T Kosuge, K Shimada.   

Abstract

The results of hepatectomy, percutaneous ethanol injection therapy and transcatheter arterial embolization for small hepatocellular carcinoma (HCC) of 3 cm or less in diameter from the published literature were compared with the authors' experiences with surgical treatment. The survival rates for those treated by hepatectomy and ethanol injection were almost the same, being more than 90% at 1 year and 70% at 3 years. The overall results achieved by embolization were inferior to those achieved by the other two therapeutic modalities, although the 1 year survival rate was not worse. The cancer-free survival rates after hepatectomy and ethanol injection were also similar. Most of the patients with small HCC had associated liver cirrhosis or chronic active hepatitis, but the degree of liver dysfunction and the level of hepatic reserve varied. Anatomically, the number, size, and location of the cancer also varies. Choice of treatment for small HCC should be made based upon the degree of liver function and the anatomic status of the cancer. For example, a patient with multiple (more than four) cancer nodules is a good candidate for embolization. Ethanol injection is indicated for a small HCC, deeply seated in a severely diseased liver. Hepatectomy is the first choice for a small HCC situated near the surface of a liver with relatively good liver function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655100     DOI: 10.1111/j.1440-1746.1991.tb00879.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute.

Authors:  Yoichi Okada; Hiroyasu Ina; Kazunori Kubota; Yoshiro Himeno; Toshihiko Wakita; Isamu Ohashi; Naoya Gomi; Tetsuo Yoshida; Sunao Mae; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

2.  Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study.

Authors:  Zhi Li Wang; Ping Liang; Bao Wei Dong; Xiao Ling Yu; De Jiang Yu
Journal:  J Gastrointest Surg       Date:  2007-10-18       Impact factor: 3.452

Review 3.  [Diagnosis and therapy of hepatocellular carcinoma].

Authors:  H Reinwald
Journal:  Med Klin (Munich)       Date:  1997-11-15

4.  Acoustic droplet vaporization for enhancement of thermal ablation by high intensity focused ultrasound.

Authors:  Man Zhang; Mario L Fabiilli; Kevin J Haworth; Frederic Padilla; Scott D Swanson; Oliver D Kripfgans; Paul L Carson; Jeffrey Brian Fowlkes
Journal:  Acad Radiol       Date:  2011-06-23       Impact factor: 3.173

5.  Surgical resection versus open-approach radiofrequency ablation for small hepatocellular carcinomas within Milan criteria after successful transcatheter arterial chemoembolization.

Authors:  Jianyong Lei; Wentao Wang; Lunan Yan
Journal:  J Gastrointest Surg       Date:  2013-10       Impact factor: 3.452

6.  Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy.

Authors:  Y Horiguchi; B Sekoguchi; H Imai; T Suzuki; H Kubo; H Itoh; M Itoh
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.